What are the economic barriers of antibiotic R&D and how can we overcome them?

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015

(2018) Eili Y. Klein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps

(2017) Victoria L Simpkin et al.   JOURNAL OF ANTIBIOTICS

Antibiotics in the clinical pipeline at the end of 2015

(2016) Mark S Butler et al.   JOURNAL OF ANTIBIOTICS

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach

(2016) John H Rex et al.   LANCET INFECTIOUS DISEASES

Alternatives to antibiotics—a pipeline portfolio review

(2016) Lloyd Czaplewski et al.   LANCET INFECTIOUS DISEASES

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis

(2016) Ruth Kelly et al.   LANCET INFECTIOUS DISEASES

A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility

(2016) David M. Brogan et al.   Globalization and Health

Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipeline

(2016) David M. Brogan et al.   SOCIAL SCIENCE & MEDICINE

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics

(2015) Matthew J Renwick et al.   JOURNAL OF ANTIBIOTICS

Research and Development of Antibiotics: The Next Battleground

(2015) David M. Shlaes   ACS Infectious Diseases

Discovery and preclinical development of new antibiotics

(2014) Diarmaid Hughes et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model

(2013) David M Brogan et al.   Globalization and Health

3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

(2012) A. D. So et al.   BMJ-British Medical Journal

Challenges of Antibacterial Discovery

(2011) L. L. Silver   CLINICAL MICROBIOLOGY REVIEWS